. 2000 Sep;121(3):506–514. doi: 10.1046/j.1365-2249.2000.01317.x

Table 1.

Lymphocyte subsets and NK cell subsets (based on the established NK markers CD16 or CD56) for normal subjects (n = 19), common variable immunodeficiency (CVID) (n = 11) and X-linked agammaglobulinaemia (XLA) (n = 6) patients.

Population (subpopulation)	Normals, cells/μl	CVID cells/μl	XLA cells/μl	P (CVID versus controls)	P (XLA versus controls)
CD56⁺	218	94	129	0·004	NS
CD56⁺57⁻	149	70	109	0·02	NS
CD56⁺57⁺	57	27	26	NS	NS
CD56⁺3⁻	183	46	70	0·002	NS
CD56⁺3⁻8⁻	115	36	54	0·006	NS
CD56⁺3⁻8^dim	45	17	23	0·0003	NS
CD56⁺3⁺	51	33	56	NS	NS
CD56⁺3⁺8⁻	6	8	40	NS	0·04
CD56⁺3⁺8^dim	11	6	8	NS	NS
CD56⁺3⁺8^bright	15	16	4	NS	0·02
CD16⁺	247	102	144	0·006	NS
CD16⁺57⁻	166	80	107	0·0009	0·01
CD16⁺57⁺	42	19	14	NS	NS
CD16⁺3⁻	199	88	135	0·01	NS
CD16⁺3⁻8⁻	139	74	103	0·01	NS
CD16⁺3⁻8^dim	52	14	29	0·0002	NS
CD16⁺3⁺	9	10	13	NS	NS
CD16⁺3⁺8⁻	2	1	1	0·04	NS
CD16⁺3⁺8^dim	1	1	2	NS	NS
CD16⁺3⁺8^bright	8	6	9	NS	NS
Lymphocytes	1898	1347	1499	NS	NS
CD3⁻8⁻	511	515	265	NS	0·003
CD3⁻8^dim	59	19	27	0·0001	0·04
CD3⁺	1240	822	1183	NS	NS
CD3⁺8⁻	764	523	834	NS	NS
CD3⁺8^dim	52	32	35	NS	NS
CD3⁺8^bright	362	235	364	NS	NS

The numbers represent the median of cells per microlitre.

P, P value based on Mann–Whitney U-test and compared with normal subjects. NS (not significant), P > 0·05.